Home / Blog / Product Liability / Hydrochlorothiazide Tablets recalled over foreign tablet identification

Hydrochlorothiazide Tablets recalled over foreign tablet identification

Posted on August 4, 2015 9:38 am under Product Liability

A consumer level recall of one lot of Hydrochlorothiazide Tablet 25 mg 1000-count bottle has been initiated by Unichem Pharmaceuticals (USA), Inc. after learning about a Clopidogrel tablet found in one bottle of the product, the U.S. Food and Drug Administration reported on Thursday, July 30.

When ingested, Clopidogrel may cause bleeding and bruising, among other side-effects. A missing dose of Hydrochlorothiazide may also cause patients to suffer from edema and high blood pressure. Affected tablet bottles bear Lot # GHYL15028 and an Expiration of April, 2018, and were sold to different wholesalers, retailers, and pharmacies nationwide between May 21 and May 28 this year.

Pharmaceutical companies have the responsibility to ensure that all products are manufactured, labeled, and delivered in a way that would not compromise consumer safety. We at Habush Habush & Rottier S.C. ® might be able to help you if you have been harmed by a defective medicine in Milwaukee. Call us at (414) 271-0900 to know more about your eligibility in filing a product liability lawsuit today.